|
MTR expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.32859999458069E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.02849967326324E-10 |
| Normal-vs-Stage2 |
3.32530000002329E-06 |
| Normal-vs-Stage3 |
1.785510E-02 |
| Normal-vs-Stage4 |
4.265700E-02 |
| Stage1-vs-Stage2 |
6.865800E-01 |
| Stage1-vs-Stage3 |
2.366600E-01 |
| Stage1-vs-Stage4 |
8.229400E-01 |
| Stage2-vs-Stage3 |
2.185400E-01 |
| Stage2-vs-Stage4 |
6.638800E-01 |
| Stage3-vs-Stage4 |
6.381000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.6136000002831E-07 |
| Normal-vs-AfricanAmerican |
5.52200000170089E-08 |
| Normal-vs-Asian |
3.29489999995047E-06 |
| Caucasian-vs-AfricanAmerican |
3.323200E-01 |
| Caucasian-vs-Asian |
3.302700E-03 |
| AfricanAmerican-vs-Asian |
7.388200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.74489999951832E-07 |
| Normal-vs-Female |
1.67810999999185E-05 |
| Male-vs-Female |
3.820000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.14710000000706E-05 |
| Normal-vs-Extreme_Weight |
1.44010026126296E-10 |
| Normal-vs-Obese |
9.376300E-04 |
| Normal-vs-Extreme_Obese |
1.953940E-04 |
| Normal_Weight-vs-Extreme_Weight |
3.631600E-01 |
| Normal_Weight-vs-Obese |
1.484150E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.600000E-01 |
| Extreme_Weight-vs-Obese |
2.256000E-03 |
| Extreme_Weight-vs-Extreme_Obese |
8.070800E-01 |
| Obese-vs-Extreme_Obese |
2.056800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.917520E-03 |
| Normal-vs-Age(41-60Yrs) |
3.80789999999687E-05 |
| Normal-vs-Age(61-80Yrs) |
1.26170000003256E-08 |
| Normal-vs-Age(81-100Yrs) |
1.53639999999067E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.164400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.763400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.248820E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.900200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.341700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.346200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.76169999594111E-08 |
| Normal-VS-Type2 PRCC |
3.85059999996606E-07 |
| Normal-VS-KIRP CIMP |
5.764500E-03 |
| Normal-VS-Unclassified PRCC |
1.033730E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.514600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.849200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.787800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.043400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.289650E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.883200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.54159999998793E-06 |
| Normal-vs-N1 |
3.330500E-02 |
| Normal-vs-N2 |
4.579500E-02 |
| N0-vs-N1 |
1.401620E-01 |
| N0-vs-N2 |
6.621400E-01 |
| N1-vs-N2 |
7.867000E-01 |
|
|
